Welcome to the front line of preventive care.

We stand with health professionals who are ready to fight the silent damage caused by Advanced Glycation End products (AGEs) and who believe in acting before symptoms appear.

Our mission

We’re on a relentless mission
to put AGEs at heart of preventive care

For over two decades, we’ve worked to establish AGEs as essential biomarkers for chronic and perioperative risk. Today our technology helps health professionals predict complications earlier, personalize treatment and prevent long-torm damage before it begins.

Why AGEs matter

AGEs are dangerous compounds formed
through non-enzymatic glycation

Advanced Glycation End products (AGEs) crosslink and accumulate in tissue, while oxidative stress and chronic inflammation further drive their formation.
AGEs accumulate silently - before symptoms appear

AGEs build up in tissues years before clinical symptoms emerge, reflecting long-term metabolic stress. Measuring AGEs uncovers this hidden damage early, adding vital context beyond short-term markers like HbA1c.

By binding to collagen and elastin, AGEs stiffen blood vessels, reduce repair capacity and accelerate visible aging.
Measuring AGEs with the Reader uncovers this hidden
damage early, offering crucial insights for prevention and
care.

Elevated AGE levels are linked to diabetes complications, cardiovascular disease, kidney failure and more. They independently predict morbidity and mortality, making them key drivers of chronic pathology.

AGEs build up in tissues years before clinical symptoms emerge, reflecting long-term metabolic stress. Measuring AGEs uncovers this hidden damage early, adding vital context beyond short-term markers like HbA1c.

Medical
Professionals

Improve risk prediction, guide treatment, and support better outcomes using AGE measurements.

Integrative
Health Professionals

Measure AGEs and guide clients toward better metabolic health and vitality.

Technology
partners

Integrate AGE measurement
to unlock new market opportunities.

Our Solutions

Innovative products

Diagnoptics develops non-invasive technologies that measure Advanced Glycation End-products (AGEs), which are powerful biomarkers linked to metabolic health and biological aging.

Our solutions give clinicians and health professionals objective insights that support better decisions, earlier detection and more personalized care.

Health impact

AGEs reveal the long-term metabolic stress your patients carry and the risks they face

Persistent in tissues for years, AGEs offer a unique window into cumulative damage and chronic disease progression. 

Accumulation of AGEs

AGEs bind to long-lived proteins, persisting in tissues for years and reflecting cumulative metabolic stress.

Effects of AGEs

Advanced Glycation End products disrupt tissue function and accelerate vascular and metabolic disease.

Measuring AGEs

Non-invasive skin autofluorescence enables rapid, reproducible assessment of AGE levels in clinical practice.

AGE Interventions & Lifestyle

Targeted diet, exercise, and emerging therapies can lower AGE burden and improve outcomes.

0<span>million</span>
Cardiovascular disease
Absolute deaths have risen sharply from 12M in 1990 to 19.8M in 2022, largely due to population growth and aging.
0<span>million</span>
DM2
DM2 prevalence is expected to increase to 783M by 2045. The direct death toll from DM2 was estimated at 1.6M in 2021.
0%
CKD
With 800M cases, CKD accounted for more than 1.2M deaths in 2017 and is projected to become one of the top 5 causes of death.
0<span>million</span>
Alzheimer’s & dementia
With 55M cases in 2021 and 10M new cases per year, total cases are estimated to reach 150M by 2050.
0%
Cancer
Cancer prevalence is expected to rise from 20M new cases in 2022 to 35M new cases in 2050 — an increase of 75%.

Strategic partnerships

Collaboration drives progress

We work closely with leading universities, hospitals and research institutes worldwide. These partnerships validate our technology, expand applications, and ensure that AGE measurement continues to advance clinical and practical use.

Contact us

Get in touch
with our team

Whether you are a clinician, researcher or partner, we are happy to discuss collaborations, provide support or explore distribution opportunities. Please leave your details and our team will get back to you.

Download case study

Please leave your name, organization and email to download this AGE Reader case study.